Fibrodysplasia Ossificans Progressiva Market Overview
The Fibrodysplasia Ossificans Progressiva Market is experiencing significant growth driven by increasing awareness of this rare genetic disorder and expanding research investments. FOP is characterized by abnormal bone formation in muscles and connective tissues, severely limiting mobility and quality of life. The market was valued at $0.81 billion in 2024 and is projected to reach $2.5 billion...
0 Comments 0 Shares 10 Views 0 Reviews